The purpose of this study is to evaluate health status of uncontrolled Chronic Obstructive Pulmonary Disease (COPD) patients in response to treatments in clinical practice.

MC MD

Inclusion Criteria:

1. Provision of informed consent prior to any study specific procedures
2. Male or non-pregnant female aged >40 years
3. A clinical diagnosis of COPD with FEV1/ FVC <0.70 and require combination or modified therapy
4. Smoke > 10 Pack Year

Exclusion Criteria:

1. Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
2. Participation in a clinical study (precluding non-interventional study or registry) during the last 3 months

Primary care and Specialty care in 20 centers nationwide in Thailand